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Yersinia enterocolitica infection in children
JACOMINA A. A. HOOGKAMP-KORSTANJE, MD, PHD AND VIRGINIA M. M. ST0 LK-ENGELAAR, MD
The clinical presentation, course and outcome 
of Yersinia enterocolitica infection was studied 
prospectively in 125 children. Enteric forms oc­
curred in 114 children (92 enteritis, 20 pseudoap­
pendicitis, 2 chronic ileitis), of whom 17 also had 
extramesenteric manifestations; 11 children had 
one or more extramesenteric forms without en­
teric disease. Enteritis occurred more frequently 
in young children whereas serious forms and 
extramesenteric forms were more common in 
children older than 6 years of age (P < 0.001). 
Arthritis was observed in 13 children and exten­
sive lymphadenopathy in 11; 1 child had septice­
mia with pleurisy, 1 had vasculitis, 1 had chole­
cystitis and 4 had erythema nodosum. Diagnosis 
was established by positive culture in 100 (80%) 
children and by agglutinin test in 11 of 45 (24%), 
demonstration of circulating specific anti-IgA 
and anti-IgG to Yersinia outer membrane pro­
teins in 47 of 48 (98%) and detection of antigen in 
biopsies in 28 of 33 (85%) children. The 2 latter 
methods were superior to the agglutinin test. 
Serotype 03 and 09 predominated. The fre­
quency and seriousness of complications may 
justify the use of antibiotics for Yersinia enteritis 
in children 6 years of age or older.
INTRODUCTION
The predominant form of Yersinia enterocolitica in­
fection in children is an enteric illness with or without 
mesenteric lymphadenitis.1,2 Systemic infections in­
cluding extramesenteric lymphadenitis, metastatic in­
fections of various organs and septicemia can also 
occur.3 Postinfectious complications such as arthritis 
and erythema nodosum are uncommon in children.4 
Diagnosis of the chronic and more complicated forms of 
disease can be difficult3,5 because routine diagnostic 
methods such as stool culture and serology can become
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negative after the acute phase.5 This may contribute to 
an underestimation of the disease. In 1986 we intro­
duced other diagnostic methods: determination of class 
specific serum IgA and IgG antibodies against outer 
membrane proteins4 and antigen detection in biop­
sies.6, 7 This study reports the incidence, course, effects 
of treatment and outcome of yersiniosis in children 
during a 9-year surveillance period in an endemic area.
MATERIALS AND METHODS
Patients were identified from specimens sent to the 
Public Health Laboratory in Friesland (the Nether­
lands). This laboratory serves a province of 700 000 
inhabitants with 8 general hospitals (2100 beds) and 
260 general physicians. The study period was from 
July 1, 1982, to January 1, 1991. Y. enterocolitica 
infection was diagnosed in 887 patients (adults and 
children) by culture, serology and antigen detection. A 
physician was asked to observe each patient with 
proved Yersinia infection for at least 2 months to 
obtain information on specific symptoms (diarrhea, 
nausea, vomiting, fever, weight loss, lymphadenitis, 
erythema nodosum, arthritis, icterus, complications, 
duration of disease, family history), clinical course, 
effects of treatment and outcome. A standard form to 
record all data was used. Complete record forms were 
obtained from 125 children. These patients are pre­
sented in this study.
Feces were inoculated onto Yersinia selective agar 
(Oxoid CM653), onto deoxycholate citrate agar (Oxoid 
CM35) and into Rappaport broth.8 Plates were incu­
bated at 22°C for 48 h; broth was incubated at 22°C for 
72 h and then subcultured onto the same agar media. 
Colonies suspected to be Yersinia were isolated and 
identified. Other materials (pus, blood) were routinely 
cultured for aerobic and anaerobic bacteria and in 
particular for Yersinia on selective agar and in Rappa­
port broth, incubated at 22°C for 72 h. Pus was also 
stored for cold enrichment in phosphate buffer (pH 7.0) 
at 4°C for 3 weeks and then subcultured onto Yersinia- 
selective agar and sheep’s blood agar.
The in vitro susceptibilities to amoxicillin, amoxicil- 
lin-clavulanate, cefuroxime, ceftazidime, gentamicin, 
trimethoprim-sulfamethoxazole, doxycycline and 
chloramphenicol was determined for all strains by 
microtiter broth dilution according to the recommenda­
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tions of the National Committee for Clinical Labora­
tory Standards.9
Serum samples were titrated against unheated sus­
pensions (optical density, MacFarland Standard 5) of 
Y. enterocoliiica serotype 03, 05.27, 06.30, 07.8, 08
and 09 and Yersinia pseudotuberculosis serotypes I to 
VI grown at 22°C for 48 hours, with a standard agglu­
tination test.5,7 A titer of antibody >1:160 was signif­
icant.
Specific IgA and IgG antibodies against purified
plasmid-encoded virulence-associated Yersinia outer
membrane proteins (Yops) of Y. enterocoliiica serotype
08 (strain WA-314; Dr. C. Pai, Montreal, Canada) were
* 6demonstrated in sera by immunoblotting techniques. 
Antigens (Mr 25 kilodaltons (kDa)^ Yop E, 36 kDa = 
Yop D, 38 kDa = V antigen, 46 kDa = Yop H and 58 
kDa = Yop M) were blotted onto a nitrocellulose filter. 
Sera were diluted 1:100 in phosphate-buffered saline- 
Tween (150 mM NaCl, 20 mM Na2HP04 (pH 7.0) and 
0.5% Tween 20) and incubated with the antigen-coated 
nitrocellulose strips overnight at 22°C. The IgG and 
IgA antibody-anti gen complexes formed were visual­
ized according to the methods of Blake et al.10 Control 
strips were reacted with human acute sera (culture- 
positive Y. enterocoliiica infection) containing antibod­
ies to the Yops. Positive reaction (IgA and IgG) in 
immunoblotting with at least two identical Yops was 
judged significant.
Specimens from patients (lymph nodes, biopsy ma­
terials, pus, enteric preparations) were investigated 
with serotype-specific antisera against serotypes 03, 
05.27, 08 and 09 and monospecific antisera against 
YadA (another plasmid-encoded virulence-associated 
outer membrane protein, Mv 220 kDa6) and Yop H for 
the presence of Y. enterocolitica bacilli by indirect 
immunofluorescence.7
RESULTS
A total of 125 children (61 females, 64 males) were 
evaluated. The age distribution and the various forms 
of yersiniosis are shown in Table 1. Eighty-four chil­
dren had uncomplicated enteritis and 41 had compli­
cated forms. Uncomplicated enteritis occurred more 
often in young children; serious and extramesenteric 
forms more often occurred in children above the age of 
6 years (P < 0.001).
Enteritis was characterized by diarrhea in 68%, 
abdominal pain in 40% and fever in 33%; 26 (30%) 
children were hospitalized because of dehydration (Ta­
ble 2). Diarrhea was rather mild, the stool was not 
bloody and the duration was about 1 week in 22%, 2 to
4 weeks in 55 and 23% of the children had 3 to 4 periods 
of diarrhea for 2 to 12 months. Abdominal pain, local­
ized in the right lower quadrant, was usually accom­
panied by diarrhea and was prominent. In 9 (10%) 
patients pain was the only symptom. Enteritis was
TABLE 1. Demographic data of 125 children with
yersiniosis
--------------------------------- — - —  —  — —
Age Range (Years)
Disease No.
0-5 6 - 1 0 11-15
Enteric forms
No. 114 6 6 2 0 28
Enteritis 84 61 1 1 1 2
Enteritis with 8 4 2 2
complications
1 2Appendicular 2 0 1 7
syndrome
Ileitis 2 2
Extramesenteric forms
No. 28 5 8 15
(+ enteric) 17 4 5 8
Septicemia 1 1
1Vasculitis 1
Lymphadenopathy 1 1 1 3 7
Hepatitis 1 1
8Arthritis 13 1 4
Erythema nodosum 4 3 1
35Total no. 125 67 23
TABLE 2. Age distribution, symptoms and need for 
antibiotic treatment in 84 children with uncomplicated
enteritis by Yersinia enterocolitica
Age (Years)
Clinical Data --------------------------------
0-5 6 - 1 0 11-15
No. of patients 61 1 1 1 2
Symptoms
Diarrhea 44 9 5
Fever 22 2 4
Abdominal 2 1 7 6
pain
Vomiting 16 5 2
Weight loss 1 1 4
Hospitalization 2 0 3 3
complicated by extramesenteric manifestations in 8 
children, including septicemia with vasculitis, pleurisy 
and hepatosplenomegaly (1), lymphadenopathy (1), 
erythema nodosum (2), arthritis (2) and arthritis and 
erythema nodosum (2),
Pseudoappendicular syndromes, presenting as 
“acute abdomen,” occurred in 20 patients, all but 1 
older than 6 years of age. The most important symp­
toms were acute abdominal pain, especially tenderness 
of the right lower quadrant; 5 children had fever and 3 
had diarrhea. Surgery was performed in 13 patients for 
suspected "acute abdomen.” At laparotomy mesenteric 
lymphadenitis with terminal ileitis was found with a 
normal appendix in 9 and an inflamed appendix in 4 
children; the latter 4 had also mesenteric lymphadeni­
tis. Seven of 13 operated children had extensive intra­
abdominal lymphadenitis with pseudotumorous forms;
1 also had cholecystitis. Histology on ileocecal biopsies 
showed nonspecific inflammation with diffuse lym- 
phoplasmacellular infiltrates and destruction of epi­
thelial cells. The lymph nodes also showed nonspecific 
chronic inflammation, and Y. enterocolitica bacilli 
could be demonstrated in or between the epithelial 
cells of the ileocecal biopsies and in the lymph nodes.
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Two patients had arthritis simultaneously.
Eighteen of 20 patients improved without complica­
tions, and 2 kept complaints of abdominal pain during 
the follow-up for 1 to 12 months. Both had undergone 
surgery; they were treated with antibiotics subse­
quently and recovered.
Ileitis was present in a 15-year-old girl and a 14-year 
old boy, who had chronic and relapsing, sometimes 
bloody, diarrhea with abdominal pain, fever and 
weight loss. The duration of complaints at the time of 
diagnosis was 10 months. At endoscopy the intestinal 
mucosa appeared diffusely swollen and erythematous; 
chronic inflammation and infiltration of submucosal 
and muscular areas were observed with nonspecific 
lymphocytic infiltrates, necrosis and some granulomas. 
Giant cells and fistulae were not found. Bacilli were 
found in the mucosa and submucosa and deeper in the 
infiltrates and granulomas, often associated with mac­
rophages. The girl had also polyarthritis and medias­
tinal lymphadenopathy.
Eleven patients had only extramesenteric manifes­
tations, including arthritis (7 patients), arthritis with 
erythema nodosum (1), arthritis with vasculitis (1), 
generalized lymphadenopathy with splenomegaly, 
high fever and weight loss (2 children) and liver ab­
scesses (1).
The diagnosis of Y. enterocolitica infection was es­
tablished by positive culture in 100 patients (Table 3), 
The age distribution of these patients is shown in 
Figure 1. Most culture-positive patients were found in 
the younger age group presenting with enteritis, both 
uncomplicated and complicated (89 (92) = 97%). Ten of 
20 (50%) patients with pseudoappendicitis and 1 pa­
tient with arthritis and erythema nodosum without an 
enteric form were culture-positive.
Culture-negative patients were diagnosed (Table 4) 
by agglutination (6 patients), immunoblotting (22 pa­
tients) and antigen detection (11 patients).
25
Number of patients
20
16
10
O
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Age (years)
Fig. 1. Age distribution of 100 culture-positive children with 
Y. enterocolitica infection.
TABLE 4. Positive diagnostic tests in 25 culture-negative 
children with yersiniosis, related to clinical disease
Disease IgA IgG* 
anti-Yops
No. Positive
Agglutinin
test
Antigen
detection
Enteritis 3 3 (3)f 1(3)
Appendicular syndrome 1 0 9(9) 3(8) 7(7)
Ileitis 2 1 (1) 0 (1) 2 (2)
Extramesenteric forms 1 0 9(9) 3(8) 2 (2)
* Serum anti-IgA and IgG to Yops by immunoblotting, agglutinin test and antigen 
detection in biopsies, 
t  Numbers in parentheses, number of tests performed.
Overall agglutinins were found in 11 (24%) of 45 sera 
tested and specific IgA and IgG antibodies to Yops in 47 
(98%) of 48 sera (98%) tested. Antigen detection in 
biopsies or surgical materials diagnosed 28 of 33 (85%) 
patients tested, Serum specimens were available from
11 culture-positive children. In a comparison of sensi­
tivity and specificity of the serologic tests, it was found 
that 3 of 11 culture-positive children had circulating 
agglutinins vs. 10 with anti-IgA and anti-IgG to Yops. 
Seven of these children had complicated forms of dis­
ease.
TABLE 3. Positive diagnostic tests in 125 children with yersiniosis, related to clinical disease
No. Positive
Disease
Culture IgA IgG Agglutinin Antigenanti-Yops* test detection
Enteric forms
Enteritis 92 89
Appendicular 2 0 1 0
syndrome
Ileitis 2
Extramesenteric 28 9
forms
Septicemia 1 1
Vasculitis 1
Lymphadenopathy 1 1 5
Hepatitis 1
Arthritis 13 3
Erythema nodosum 4 4
Total no. 125 1 0 0
13 (14) 4(16) 4(5)
1 2  (12) 2 (12) 14 (16)
1 (1) 0 (1) 2 (2)
2 1  (21) 5(61) 9(11)
1 (1) 0 (1) 1 (1)
1 (1) 1 (1) 1 (1)
7(7) 2 (6) 7(8)
1 (1) 0 (1) 1 (1)
1 0  (10) 2(7) 2(3)
2 (2) 0 (2)
47 (48) 11 (45) 28 (33)
* Serum anti-IgA and IgG to Yops by immunoblotting, agglutinin test and antigen detection in biopsies 
t  Numbers in parentheses, number of tests performed.
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The strains isolated belonged to serotypes 03 (61), patients referred to the hospital, who were the more
05.27 (2), 06.30 (3), 08-like (5) and 09 (21); eight
strains were not typable.
All strains were resistant to amoxicillin and amoxi- 
cillin-clavulanate (90% minimal inhibitory concentra­
tion (MIC90) >32 mg/liter) and 90% were susceptible to 
cefuroxime (MIC90 ^4  mg/liter), doxycycline (MIC90 <2 
mg/liter) and chloramphenicol (MIC90 ^4  mg/liter). All 
strains were susceptible to trimethoprim-sulfamethox- 
azole (MICgo 0.125 mg/liter), ceftazidime (MIC90 1 
mg/liter) and gentamicin (MIC90 1 mg/liter).
A total of 48 children were treated with antibiotics: 
32 received trimethoprim-sulfamethoxazole, 4 received 
amoxicillin, 4 received cefaclor, 4 received doxycycline,
2 received ciprofloxacin, 1 received chloramphenicol 
and 1 received gentamicin. Three clinical failures were 
observed: trimethoprim-sulfamethoxazole (2) and 
amoxicillin (1).
DISCUSSION
The incidence of yersiniosis in this part of the Neth­
erlands is estimated to be 20% that of salmonellosis.3 
This seems high compared with most European coun­
tries,11 although recent data are missing. This high 
incidence may be partly explained by better diagnosis 
by use of more sensitive and specific diagnostic meth­
ods and in particular by an increasing alertness of 
physicians participating in this prospective study.
In common with others1,5 we found the enteric form 
predominant, with the highest incidence in young chil­
dren. Probably the incidence in this age group is even 
higher inasmuch as Yersinia enteritis is often a mild 
disease at that age; probably because of this many 
children do not visit a doctor and fecal cultures are not 
made. This finding is in contrast with that of Naqvi et 
al.2 concluding that Yersinia enteritis in children is a 
serious disease with fever and bloody stools. We found 
bloody stools to be an exception in young children and 
only one-third of them had fever. We think that Naqvi’s 
study group was a selection of the more serious cases 
and not representative of the usual Yersinia enteritis 
in children. Naqvi et al. reviewed only patients seen in 
the children's hospital from whose stools Yersinia has 
been isolated at the pediatrician’s request. Most of our 
children with enteritis were evaluated by general prac­
titioners and did not require hospitalization. Severity 
of disease may also be associated with certain sero­
types. Serotype 03 and 09 strains predominated in our 
patients and they are known to be less virulent than 
the American 08 strain. Because we do not know which 
serotypes were isolated in the Naqvi study, we cannot 
evaluate this aspect. Serotype 03, however, is also 
emerging as cause of pediatric gastroenteritis in the 
United States as reported by Lee et al.12 They observed 
34 children with serious enteritis with bloody stools 
from serotype 03 infection, but they also studied only
senous cases.
Characteristic for Yersinia enteritis was its long
duration and tendency to chronicity with relapses, 
which was also reported by Lee et al.12 Abdominal pain 
was a major complaint of many children and often more
pronounced than diarrhea.
The more serious forms, pseudoappendicular syn­
drome and systemic infections, affected mainly older 
children and the frequency in that age group (40%) is 
higher than that reported by others,13 but in the same 
range as we reported earlier for adults.14
Patients with complicated forms were often culture- 
negative; only a minority had significant agglutinin 
titers. Using more specific and novel techniques we 
could recognize Yersinia-associated disease in 21 pa­
tients otherwise missed. Comparing the agglutination 
reaction with determination of specific anti-IgA and 
anti-IgG to Yops in culture-positive patients, it was 
clear that the anti-Yops are far more sensitive and 
reliable for diagnosis of Yersinia-associated disease. 
This was previously shown.6,7> 14,15
We could not associate the systemic forms with 
predisposing factors such as malignancy, hematologic 
disorders and iron overload.16
We were impressed by the severity of the lymphad­
enopathy, which resembled that of disorders such as 
malignant lymphoma. Seven children had an extensive 
intraabdominal mass found at operation for acute ab­
domen and four children had generalized lymphadeni­
tis, all accompanied by high fever and weight loss. This 
syndrome existed for several weeks before the diagno­
sis was made and disappeared completely after appro­
priate antibiotic therapy.
Yersinia-associated arthritis is a complication often 
reported in adults. A sporadic case has been reported in 
pediatrics.17 We found it a complication in 10% of our 
children. The youngest child with arthritis in our series 
was 2 years of age, the other children were 7 years or 
older. Three children had positive stool cultures and six 
developed arthritis after an enteric form of yersiniosis, 
but seven children had arthritis without preceding 
diarrhea, although one of them had a positive stool 
culture. This means that yersiniosis is in the differen­
tial diagnosis of patients with arthritis, in particular 
when erythema nodosum is a concomitant finding as it 
was in two of our children.
Why some patients cannot recover from Yersinia 
enteritis and develop a chronic form is unclear. Persis­
tence of infection and antigens may be responsible for 
or involved in these complications.15
Antibiotic treatment does not influence the course 
and duration of uncomplicated enteritis,14,18 and cur­
rently we do not advise antibiotic treatment in children 
younger than 6 years of age with enteritis in our area.
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Whether antibiotics might be effective in preventing 
complications is difficult to establish, but their fre­
quency and seriousness in children 6 years of age and 
older may justify their use in this age group. The 
strains cultured belonged to the serotypes common in 
Europe,19 and their antibiotic susceptibility pattern 
was consistent with the findings of others.20 The treat­
ment results with trimethoprim-sulfamethoxazole, the 
drug most often used, were satisfactory.
This study, in which novel diagnostic methods were 
used, showed that Y, enterocolitica infection may be 
underdiagnosed if one is limited to standard tech­
niques. The novel tests provided insight into conditions 
associated with yersiniosis. The clinical significance of 
the etiologic diagnosis of yersiniosis is an important 
one, to avoid primarily inappropriate therapy. Too 
often unnecessary surgical procedures or treatment 
with ineffective antibiotics, antiinflammatory agents, 
corticosteroids or even cytotoxic drugs are used for 
yersiniosis in the absence of the correct diagnosis.3,14 
Complicated forms of enteritis and the extramesenteric 
forms must be treated with appropriate antibiotics. 
Because these antibiotics are different from those rou­
tinely used in severe infections of unknown origin14,21 
it is very important to make the right diagnosis. Wrong 
therapy may lead to prolonged hospitalization and 
occurrence of late complications, especially in older 
children.
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